SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-012886
Filing Date
2020-07-09
Accepted
2020-07-09 07:00:35
Documents
18
Period of Report
2020-07-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29903
2 ex99-1.htm EX-99.1 19075
3 ex99-1_001.jpg GRAPHIC 60315
4 ex99-1_002.jpg GRAPHIC 192567
5 ex99-1_003.jpg GRAPHIC 113906
6 ex99-1_004.jpg GRAPHIC 73871
7 ex99-1_005.jpg GRAPHIC 136468
8 ex99-1_006.jpg GRAPHIC 112515
9 ex99-1_007.jpg GRAPHIC 97701
10 ex99-1_008.jpg GRAPHIC 129499
11 ex99-1_009.jpg GRAPHIC 84454
12 ex99-1_010.jpg GRAPHIC 112641
13 ex99-1_011.jpg GRAPHIC 136493
14 ex99-1_012.jpg GRAPHIC 117871
15 ex99-1_013.jpg GRAPHIC 132210
16 ex99-1_014.jpg GRAPHIC 122733
17 ex99-1_015.jpg GRAPHIC 137070
18 ex99-1_016.jpg GRAPHIC 46624
  Complete submission text file 0001493152-20-012886.txt   2540121
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 201019520
SIC: 2834 Pharmaceutical Preparations